Internal Medicine, Hematology & Oncology · Orlando, FL
NPI
1235257668
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
922 Lucerne Ter
Orlando, FL, 32806
Phone (407) 426-8660
Groups this clinician bills Medicare through
Medicare paid, 2024
$213K
12,710 services
Medicare patients, 2024
390
Average age 73
Drug cost, 2024
$7.8M
1,917 prescriptions
Company payments, 2025
$3,377
From 41 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Carlos A Gadea was code 99231 (hospital e&m - subsequent), 1,049 times for 101 patients. In total Carlos A Gadea billed 12,710 services in 55 codes, and Medicare paid $213K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-07-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99231 Hospital E&M - Subsequent | Facility | 1,049 | 101 | $38.65 | $41K |
| 99232 Hospital E&M - Subsequent | Facility | 780 | 197 | $61.07 | $48K |
| 88185 Surgical Pathology Examination | Office | 725 | 23 | $17.25 | $13K |
| 99214 Office E&M - Established | Office | 432 | 107 | $89.34 | $39K |
| 99233 Hospital E&M - Subsequent | Facility | 298 | 129 | $92.42 | $28K |
| 36415 Venipuncture Blood Collection | Office | 286 | 81 | $8.62 | $2,465 |
| 85025 Blood Count | Office | 286 | 81 | $7.58 | $2,169 |
| 99223 Hospital E&M - Initial | Facility | 156 | 140 | $134.75 | $21K |
| 96372 Injection Administration | Office | 117 | 39 | $10.22 | $1,196 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 105 | 38 | $0.94 | $98.78 |
| 96365 Intravenous Infusion, Hydration | Office | 47 | 14 | $42.70 | $2,007 |
| 88189 Surgical Pathology Examination | Office | 27 | 25 | $63.83 | $1,723 |
| 88184 Surgical Pathology Examination | Office | 25 | 23 | $55.34 | $1,383 |
| 99205 Office E&M - New | Office | 20 | 20 | $133.88 | $2,678 |
| 99213 Office E&M - Established | Office | 16 | 11 | $68.36 | $1,094 |
By year: 2022 $186K for 4,132 services; 2023 $196K for 4,241 services; 2024 $213K for 12,710 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88185 Surgical Pathology Examination | 725 | 23 | $17.25 | $13K |
| 36415 Venipuncture Blood Collection | 286 | 81 | $8.62 | $2,465 |
| 85025 Blood Count | 286 | 81 | $7.58 | $2,169 |
| 88189 Surgical Pathology Examination | 27 | 25 | $63.83 | $1,723 |
| 88184 Surgical Pathology Examination | 25 | 23 | $55.34 | $1,383 |
Medicare prescription drug claims, 2024
In 2024, the drug Carlos A Gadea prescribed most often to Medicare patients was Eliquis (Apixaban), with 143 prescriptions and refills. In total Carlos A Gadea wrote 1,917 Medicare prescriptions that cost $7.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 143 | 210 | 34 | $122K |
| Anastrozole Generic | 103 | 245 | 28 | $1,517 |
| Abiraterone Acetate Generic | 77 | 77 | Under 11 | $111K |
| Dexamethasone Generic | 69 | 96 | 16 | $2,311 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 66 | 66 | 21 | $2,281 |
| Tamoxifen Citrate Generic | 65 | 148 | 20 | $1,767 |
| Lenalidomide Generic | 64 | 64 | Under 11 | $897K |
| Prednisone Generic | 59 | 63 | 14 | $446 |
| Calquence Acalabrutinib Maleate | 51 | 51 | Under 11 | $750K |
| Xgeva Denosumab | 48 | 48 | Under 11 | $153K |
| Imbruvica Ibrutinib | 42 | 42 | Under 11 | $667K |
| Darzalex Faspro Daratumumab-Hyaluronidase-Fihj | 38 | 38 | Under 11 | $805K |
| Exemestane Generic | 38 | 38 | Under 11 | $7,896 |
| Oxycodone Hcl Generic | 37 | 37 | Under 11 | $549 |
| Ondansetron Hcl Generic | 34 | 34 | 17 | $738 |
Brand drugs: 856 claims; generic drugs: 1,061 claims; opioid claims: 135.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Carlos A Gadea $3,377 ($3,377 in general payments such as food, travel and fees) from 41 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $401.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 14 | $401 |
| Pfizer Inc. PFE | 10 | $227 |
| Merck Sharp & Dohme LLC MRK | 9 | $223 |
| Novartis Pharmaceuticals Corporation NVS | 9 | $206 |
| Boston Scientific Corporation BSX | 3 | $193 |
| Janssen Biotech, Inc. JNJ | 10 | $184 |
| Celgene Corporation BMY | 5 | $145 |
| Eisai Inc. 4523.T | 6 | $125 |
| GlaxoSmithKline, LLC. GSK | 5 | $115 |
| Incyte Corporation INCY | 5 | $114 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.